Results 281 to 290 of about 127,348 (379)

P53 Efficacy and toxicity of mycophenolate in systemic autoimmune diseases

, 2006
Ige George, Prasanta Padhan, Z Vasuki, J. Mathew, Y Jerang, Debashish Danda   +5 more
openalex   +1 more source

The Role of Belatacept‐Use and Senescence on Infectious and Mortality Complications After Kidney Transplantation

Transplant Infectious Disease, EarlyView.
ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam, Abdinoor Abdi, Wyatt Tarter, Ben Langworthy, Adam Bregman, Karam M. Obeid   +5 more
wiley   +1 more source

Toxic agranulocytosis following nitazoxanide treatment for norovirus diarrhea in a kidney transplant recipient: A case report and review of literature. [PDF]

World J Transplant
Grépilloux D, Guéneau C, Weinhard J, Richaud R, Chevallier E, Jouve T, Dusserre J, Rostaing L.   +7 more
europepmc   +1 more source

Clinical use of immunosuppressants [PDF]

, 2005
Fung, JJ, Schonder, KS, Starzl, TE, Weber, RJ   +3 more
core  

Clinical implications of imlifidase interference in antibody screening and transfusion management

Transfusion, EarlyView.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani, Aiko P. J. de Vries, Arjan Albersen   +2 more
wiley   +1 more source

A Multi-National Survey on Immunosuppressive Regimens and Mycophenolate Monitoring Practices after Kidney Transplantation.

Kidney Blood Press Res
Sharma S, Kausman J, Craig S, Metz D.
europepmc   +1 more source

Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risks. [PDF]

World J Gastrointest Pharmacol Ther
Mujumdar S, Shaikh S, Chan SY, Yekula A, Weinberg DR, Ansari NS, Jerez Diaz D, McPherson SB, Levstik M, Moon AM, Twohig P.   +10 more
europepmc   +1 more source

Recognition of Transfusion With Microcytic Packed Red Blood Cells on ADVIA 2120i RBC V/HC Cytograms: A Case Report

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 3‐year‐old, intact female Havanese dog was presented for treatment of a relapse of suspected immune‐mediated anemia and thrombocytopenia. Over the course of treatment, the patient's anemia appeared to acutely transition from macrocytic and hypochromic to microcytic and hypochromic between days five and six of hospitalization.
Hannah R. Cohen, Matthew K. Wun, Jillian Haines, Sarah C. Guess, Mara S. Varvil, K. Jane Wardrop   +5 more
wiley   +1 more source

Neuropsychiatric Systemic Lupus Erythematosus: A Case Series. [PDF]

Cureus
Garcia-Smester MA, Patnaik A.
europepmc   +1 more source

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

Veterinary Dermatology, EarlyView.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain, Andrew Lowe, Elizabeth A. Mauldin   +2 more
wiley   +1 more source